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The prevailing philosophy in oncologic neurosurgery, has shifted from maximally invasive
resection to the preservation of neurologic function. The foundation of safe surgery
is the multifaceted visualization of the target region and the surrounding eloquent
tissue. Recent advancements in pre-operative and intraoperative visualization modalities
have changed the face of modern neurosurgery. Metabolic and functional data can
be integrated into intraoperative guidance software, and fluorescent dyes under
dedicated filters can potentially visualize patterns of blood flow and better define tumor
borders or isolated tumor foci. High definition endoscopes enable the depiction of tiny
vessels and tumor extension to the ventricles or skull base. Fluorescein sodium-based
confocal endomicroscopy, which is under scientific evaluation, may further enhance
the neurosurgical armamentarium. We aim to present our institutional workup of
combining different neuroimaging modalities for surgical neuro-oncological procedures.
This institutional algorithm (IA) was the basis of the recent publication by Haj et al.
describing outcome and survival data of consecutive patients with high grade glioma
(HGG) before and after the introduction of our Neuro-Oncology Center.
Keywords: fluorescence-guided surgery, fluorescein sodium, YELLOW 560nm, KINEVO, tumor segmentation,
confocal endomicroscopy, CONVIVO, brain tumors
INTRODUCTION
Modern oncological neurosurgery is marked by the consensus that all surgical interventions should
aim to attain complete tumor resection without affecting neurological function. This dogma was
finally agreed upon because low tumor burden and good neurological function has been repeatedly
shown to form the basis of any successful adjuvant treatment modality and to result in prolonged
progression-free and overall survival, whilst preserving good quality of life (1–3).
The combination of different imaging modalities for pre-operative planning and intraoperative
guidance should always aim at clearly identifying the targeted tumor that can be extremely
heterogeneous. Currently, the integration of various functional imaging data, such as functional
magnetic resonance imaging (fMRI), into neuronavigation allows for increased safety when
approaching vulnerable, eloquent structures. Fluorescence-guidance can further support the
neurosurgeon’s eye and experience in visualizing the tumor mass, scattered tumor spots, infiltrated
zones and rims, and patterns of blood flow, and can ultimately confirm a tumor-free cavity (4, 5).
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However, in the daily routine of a neuro-oncology center
(NOC), it is always mandatory to obtain and employ the
desired imaging modality in a cost-effective, fast, and
uncomplicated manner. Patients must be protected from
redundant assessments, and, above all, “technical overkill”
in the operating theater must be avoided. Furthermore,
critical self-reflection and monocentric or multicenter
complication analyses should be consistently generated and
published to properly outline advantages and disadvantages,
as well as clinical benefits and limitations of the institutional
algorithm (IA). This approach is the only way that the most
important factors, namely the surgical skills and experiences
of neurosurgeons, are effectively supported by innovative
technical adjuncts.
In 2017, we published our outcome and survival data
of consecutive patients with high grade glioma since the
introduction of a certified NOC in 2009. Since 2009, all patients
with HGG at our department have been treated according to
our IA. The current investigation has shown clear benefits
in neurological outcome, progression-free survival, and overall
survival in comparison to the equivalent data collected before
2009 (6).
The impact of the NOC organization in terms of improving
survival in patients with glioblastoma has been described
previously (6), but the detailed description of the workflow
and institutional algorithm have yet to be reported. Therefore,
the aim of this paper is to present our approach of combining
different visualization modalities that are pre- and post-
operatively employed not solely for the intraoperative depiction
of the targeted area, but also for advanced pre-operative
unmasking of the tumor structure, invasiveness, environment,
and adherences. This combination enables sophisticated
planning of the surgical approach including positioning,
craniotomy, and dissection. We strongly believe that the
interaction of a visual armamentarium provides neurosurgeons
with more sensitivity and purposefulness, especially in complex
neuro-oncologic procedures.
RESULTS
When a new patient with a suspected brain tumor is referred
to our center, structural MRI is usually initially completed
(see Table 1). Tumors without Gadolinium enhancement are
further analyzed with FET-PET, which influences the choice
of intraoperative fluorescent dyes. Proximity of the tumor
to eloquent areas results in a functional workup (fMRI and
Diffusion Tensor Imaging, DTI). All imaging data are then pre-
processed and segmented to provide the essential information
of each imaging modality. The final therapeutic decision is
made after 3D-visualization and demonstration of the case,
followed by stereotactic biopsy, open biopsy/partial resection, or
gross tumor removal. The choice of fluorescent dye depends on
the level of gadolinium enhancement and the FET-PET result
(see Table 2).
The following features of the IA (Table 2) were selected
because of their fundamental scientific interest:
TABLE 1 | Overview of our institutional imaging workup for common intracranial
lesions: magnetic resonance imaging (MRI) protocol for patients with intracranial
tumors include T1 spin echo and T2 turbo spin echo sequences with 1mm and
isotropic 3D sequences (1mm) including T1 w/gadolinium contrast (3D multiplane
reformation, MPR), T2 (3D sampling perfection with application optimized contrast
using different flip angle evolution, SPACE), 3D fluid attenuation inversion recovery,
FLAIR, and constructive interference in steady-state (CISS MRI).
Suspected
diagnosis
Low grade
glioma
High grade
glioma/
metastasis
Vascular
lesions
(aneurysms/
AVM)
Skull base
tumor
MRI SE T1 w/o
CM, SE T2,
3D MPR
w/contrast,
3D T2, 3D
FLAIR
SE T1 w/o
CM, T2, 3D
MPR
w/contrast,
3D T2, 3D
FLAIR
SE T1 w/o
CM, SE T2,
3D MPR
w/contrast,
3D TOF,
TWIST
SE T1 w/o
CM, SE T2,
3D MPR
w/contrast,
3D TOF, T2*
CISS
CT thin-sliced
skull base
(1mm)
*X X X
FET-PET X *X
fMRI, rsfMRI X X *X
DTI X X *X
CFD
simulation
*X
Xmandatory, *Xoptional.
3D time-of-flight (TOF) and time-resolved angiography with interleaved stochastic
trajectories (TWIST) sequences are obtained in vascularized tumors. Positron emission
tomography (PET) with O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) (FET-PET) is used for
non-contrast enhancing and recurrent contrast-enhancing gliomas. Functional MRI (fMRI)
and resting state (rs) fMRI are conducted for visualizing functional areas.
Pre-operative Workup–Completion of
Structural and Metabolic Neuroimaging
When a new patient with a suspicious cranial lesion is referred
to our center, neuroimaging is quickly completed according
to our institutional imaging requirements (see Table 1) that
includemagnetic resonance imaging plus isotropic 3D sequences,
computed tomography (CT), or 18F-fluorethyl tyrosine (FET)-
/18F-fluordesoxyglucose (FDG)-positron emission tomography
(PET). According to the recommendations of our daily case
conference, patients are evaluated neuro-psychologically and
consecutively undergo functional MRI and diffusion tensor
imaging (DTI).
In 2018, we published a small series of patients with glioma
that had not shown any contrast enhancement in the MRI, yet
presented with distinct metabolic activity in the FET-PET (7).
These patients had been suitable for fluorescence-guided surgery
with Fluorescein Sodium (FL) under the YELLOW 560 nm
filter (Carl Zeiss Meditec, Oberkochen, Germany). A possible
correlation between FET-PET active tumors and fluorescent
staining was assumed, facilitating surgical performance. Our
results supported the data by Rapp et al. and Pirotte et al. who
had outlined the diagnostic value of FET-PET for diagnosing hot
spots inside gliomas. Clearly, FET-PET increases intraoperative
diagnostic accuracy and helps to establish the most exact
histopathological diagnosis (8, 9).
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TABLE 2 | Institutional algorithm (IA).
Pre-operative Workup–fMRI and DTI
The aim of pre-surgical functional imaging is to maximize
the resection of lesions (tumors or metastases) as well as
to minimize post-operative functional deficits. Both factors
increase post-operative health-related quality of life (10) and
are prognostic factors for successive interventions involving
radiation- and/or chemotherapy (11, 12). In our center, pre-
surgical functional imaging is conducted with fMRI and resting
state functional (rsf) MRI for the functional localization of
cortical gray matter; diffusion-weighted imaging is used to
determine subcortical white matter tracts. fMRI is exclusively
carried out with 3-Tesla Siemens MRI scanners. Protocols
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FIGURE 1 | Integration and three-dimensional display of different structural
and functional modalities in AMRIA. The original imaging modality used for
visualization is annotated in brackets.
for mapping the sensorimotor homunculus, language location
and lateralization, and memory or retinotopic organization of
the visual cortex depend on the localization of the lesion.
Non-compliant or severely disabled patients may undergo
rsfMRI that is also used in the case of patients with
language barriers or in very young patients, awake patients
with their eyes open, or in narcotized patients. fMRI data
are analyzed with (S)tatistical(P)arametric(M)apping12 (www.
fil.ion.ucl.ac.uk/spm/software/spm12/) including the LI-toolbox
(13) and rsfMRI data with in-house generated Matlab scripts
including parts of DPARSF and the GIFT-toolbox (http://
mialab.mrn.org/software/gift/). According to fiber tracking,
diffusion-weighted images (DWI) are acquired by means
of 3T and 1.5T MRI scanners, either with 30 directions
and 3mm isotropic resolution or 64 directions with 2mm
isotropic resolution depending on the disease and patient
characteristics. The following fiber tracking modeling can be
done either deterministically with AMIRA (FEI Visualization
Sciences, France) or probabilistically by using a modified
FSL pipeline [employing Bayesian Estimation of Diffusion
Parameters Obtained using Sampling Technique (BEDPOSTX)].
Fiber tracking is conducted in advance, when mainly pyramidal
tracts, arcuate fascicles, uncinated fascicles, and optic tracts are
shown. All functional results (fMRI, rsfMRI, and DTI) can be
integrated into AMIRA (FEI Visualization Sciences, France)
(see Figure 1).
Pre-operative Workup–Tumor
Segmentation
Automatic pre-operative brain tumor segmentation is a powerful
tool for surgical planning that allows the extraction of tumor
characteristics (contrast-enhancing and non-contrast-enhancing
compartments, edema, and necrosis) from surrounding healthy
brain tissue by means of a set of MR modalities (T1 with and
without contrast agent, T2, and FLAIR) (14). Such information
may be very useful for guiding surgical interventions by defining
the extent of resection or the area of resection. There are
a number of segmentation and tumor detection algorithms,
ranging from classification or clustering approaches to deep
learning algorithms (15, 16). In our department, we have
established a tumor segmentation pipeline based on ANSTsR
[advanced normalization tools (ANTs) and the R statistical
project] using random forest-derived probabilities to determine
different tumor tissues (17) (see Figure 2).
Pre-operative Workup−3D Visualization
and Surgical Simulation
Pre-operatively, a special simulation software is employed that
condenses the essential information of the different imaging
modalities in a 3D-viewer. This software enables the surgeon
to pre-operatively envision the operative field as realistically
as possible, simulating elements such as patient and head
positioning in a virtual clamp, craniotomy, and corticotomy
in a virtual OR setting. This software has been developed and
modified by our department according to the specific needs
of neurosurgeons.
Every pre-operative imaging modality provides unique
information to characterize the lesion and its surroundings. For
the sake of visual clarity, it is essential to condense and organize
the extensive amount of anatomical and functional data. For
this reason, we developed an advanced visualization software
tool called NeuroVis, aimed at improving the understanding of
anatomical and functional relations for pre-operative planning
and intraoperative guidance in a virtual reality setting.
The essential information of every image modality is
segmented and co-registered with the 3D MPR image stack by
means of a semi-automated workflow with AMIRA. Segmented
data are then visualized with our browser- based rendering 3D
viewer NeuroVis (developed at our institute in collaboration with
1000shapes GmbH, Berlin). This tool enables neurosurgeons to
plan individually tailored treatment strategies. Planning steps
include skin incision, craniotomy, and intraoperative positioning
of the patient and the head clamp in a realistic operative setting.
We have also established an interface to a virtual reality setting
using UNITY (Unity Tec., USA) and a head-mounted display
(HTC, Taiwan). These tools help to pre-operatively envision the
operative field as realistically as possible (see Figure 3). The
prepared plan can also be transferred to a navigation system using
the stl format for intraoperative use.
Intraoperative Workup–FET-PET Positive
Non-enhancing Tumors and Fluorescence
The question of how to achieve the most effective tumor
reduction without affecting relevant motor, language, and visual
tracts continues to be highly controversial, particularly in non-
contrast enhancing gliomas in eloquent regions of the brain.
Besides the integration of functional data into neuro-navigation
and conducting surgery in an awake setting, fluorescent
visualization of the tumor may significantly increase the quality
of resection and speed up surgery. Our recently published
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FIGURE 2 | ANTsR tumor segmentation result of glioblastoma, showing labels for contrast-enhancing tumor (very light gray), necrosis (dark gray), edema (light gray)
(upper row; contrast non-enhancing tumor label is not depicted), and the corresponding FLAIR (lower row left) and T1 with contrast agency (lower row right) MR image.
experience in patients with non-enhancing gliomas with
distinct metabolic activity in FET-PET and clear intraoperative
fluorescent staining (7), in addition to the report by Bowden et
al. (18), supports the potential supplementary role of FL in cases
of low or intermediate grade glioma with high metabolic activity.
Intraoperative
Workup–Fluorescein-Enhanced Confocal
Endomicroscopy
Because of its unspecific accumulation in areas of disrupted
blood-brain barrier (BBB), FL can be applied widely irrespective
of the tumor histology in HGG (19–22), cerebral metastases
(23, 24), lymphomas (25, 26), meningiomas (27), neuromas (28),
and brain abscesses (29) for guiding microsurgical resection
under the dedicated light filter. Furthermore, FL-based confocal
endomicroscopy can be employed in vivo to obtain multiple
digital biopsies to visualize the tissue texture, enabling distinct
histological evaluation by a (remote) neuropathologist (4, 30–33).
This approach circumvents having to wait for the frozen section,
enabling the surgeon to rapidly identify the histological origin of
the lesion and delineate the tumor border much more precisely.
However, since this technique is still under scientific evaluation,
clinical data are required to outline the potential significance of
this approach (30).
Decision Making
This evaluation and the information provided by our
neuropsychologist determine whether surgery is planned
in an awake setting or under sedation. Neuro-navigation
integrating all neuroimaging devices (fMRI, CT, and PET) is
clinically routine.
Prior to surgery, we decide on the intraoperative visualization
tools to be used, depending on the suspected etiology of the
tumor, the anatomical localization, the expansion into eloquent
areas and fiber tracts, and subject to the surgical approach.
With the exception of intraoperative magnetic resonance
imaging (iMRI), our neurosurgical department comprises all
conventional technical adjuncts and personal competences of
a tertiary academic neurosurgical center: (a) Fluorescence
with dedicated light filters: fluorescein sodium (FL, YELLOW
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FIGURE 3 | Pre-operative visualization with NeuroVis 3D (upper row) and in a virtual reality setting (lower row) using a head-mounted display.
560 nm filter), 5-aminolevulinic acid (5-ALA, BLUE 400 nm
filter), and indocyanine green (ICG, FLOW 800 module);
(b) Neuronavigation, ultrasound; (c) Intraoperative monitoring
(IOM); (d) Endoscopy; and (e) Confocal endomicroscopy (still
under scientific evaluation).
Illustrative Cases
Case #1
This case describes our approach to the treatment of a
remotely recurrent, eloquently located, contrast-enhancing
astrocytoma WHO III of a 51-year-old female patient. The pre-
operative neuroimage-workup consisted of conventional MRI
(T1-weighted, axial sequence, Figure 4), FET-PET (displayed
in navigational software, axial sequence, Figure 5), and neuro-
navigation with integrated fMRI, DTI, and FET-PET (Figure 6).
The patient was surgically treated in an awake-awake setting
under fluorescence-guidance with FL (5 mg/kg) and the
YELLOW 560 nm filter (Figure 7), and the removed tumor was
examined ex vivo with the confocal endomicroscope (Figure 8).
Early post-operative contrast-enhanced MRI showed complete
removal of the contrast-enhanced lesion that was histologically
confirmed as astrocytoma WHO III.
FIGURE 4 | Pre-operative MR image (T1-weighted sequence, axial plane)
showing new contrast-enhancement distant to the former resection cavity.
This case was selected because the pre-operative
neuroimage-workup distinctively supported the indication
for surgery. The FET-PET result ruled out pseudo-progression or
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FIGURE 5 | Pre-operative FET-PET image, displayed in the navigational
software, showing strong metabolic activity in the suspicious area.
FIGURE 6 | Integration of fMRI, DTI, and FET-PET (in red) into the navigational
software, unmasking the proximity to eloquent area (arcuate fasciculus in
green, language-associated activation in cyan).
post-radiation necrosis because of the detected strong metabolic
activity that could be matched to the suspicious contrast
enhancement in the pre-operative MRI. The functional area was
displayed by means of fMRI and DTI, clearly showing proximity
but no infiltration to language-associated activation. Finally,
fluorescence-guided technique with FL impressively visualized
the tumor in vivo and ex vivo. Taken together, the included
imaging modalities resulted in complete removal of the tumor
without any functional deterioration.
Case #2
The 65-year-old female patient had a focal seizure with
paresthesia of the left upper limb and the face. Initial MRI
FIGURE 7 | Strong fluorescent staining of the tumor under the YELLOW 560
filter.
FIGURE 8 | Ex vivo examination of tumorous tissue with the confocal
endomicroscope.
showed a contrast-enhancing lesion in the left pre- and post-
central area, distant to the midline (Figure 9). The patient
additionally received motor fMRI and DTI of the pyramidal
tract that was reconstructed in 3D, including the vasculature
(Figure 10). Consequently, we indicated awake surgery because
of the proximity to the hand and upper limb area. The patient
underwent awake craniotomy under fluorescence-guidance with
very intensive fluorescence staining (Figure 11). The tumor was
completely removed, and no new neurological deficits developed.
Early post-operative MRI confirmed gross-total resection of the
lesion (Figure 12), and histology showed glioblastomaWHO IV.
According to our institutional algorithm, the patient did not
require a PET scan because of the intense contrast-enhancement
in the initial MRI; thus, we decided on administering FL (5
mg/kg) and conducting awake surgery because navigational
imaging was intraoperatively equipped with functional data
(Figure 13).
Case #3
This complex case of faintly contrast-enhancing, secondary
malignantly transformed oligodendroglioma WHO III, that had
been initially diagnosed as astrocytoma WHO II 11 years
ago, was additionally chosen to illustrate our workflow. The
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FIGURE 9 | Pre-operative MR image (T1-weighted and FLAIR sequences,
axial planes) showing circular contrast-enhancement and moderate edema.
FIGURE 10 | Sagittal view of the Amira 3D-reconstruction of the cortex, the
vessels, the ventricle, the tumor (green), the hand motor associations areas
(magenta), the tongue motor association area (yellow), and the pyramidal tract.
tumor—pre-treated with surgery, radiation, and chemotherapy—
had recurred, showing marginal contrast-enhancement in
the T1-weighted sequence in conventional MRI (Figure 14).
Consequently, FET-PET was conducted that also showed only
marginal metabolic activity (Figure 15). However, because of
the recent tumor progress and the near-eloquent localization
of the tumor in the left frontal cortex, we recommended fMRI
followed by subsequent awake craniotomy. Intraoperatively, all
imaging modalities were displayed on the navigational screen
(Figure 16), and we used fluorescence-guidance with FL (5
mg/kg) and ultrasound. Weak but still usable fluorescence was
detected, allowing for complete tumor removal based on the early
post-operative MRI (Figure 17). The neuropathological workup
showed anaplastic oligodendroglioma WHO III.
Here, all possible functional andmetabolic imagingmodalities
were included pre- and intraoperatively. Fluorescence-guidance
was helpful in this patient, although the initial MRI had only
FIGURE 11 | Strong fluorescent staining of the tumor under the YELLOW 560
filter.
FIGURE 12 | Post-operative MR image (T1-weighted and FLAIR sequences,
axial planes) confirming complete removal of the tumor.
indicated moderate blood brain barrier disruption and the initial
PET only demonstrated weak activity.
DISCUSSION
For selected patients with a brain tumor, a detailed, sophisticated
workup of different neuroimaging modalities can be of the
utmost importance for the pre-operative evaluation and/or
simulation of the neurosurgical approach, and for choosing
the technique of dissection and removal. This way, the
highest possible degree of removal of neoplastic tissue can be
attempted with a significant simultaneous increase in safety.
Despite pre-operative metabolic and functional visualization
of the targeted area by means of PET and fMRI/rsfMRI/DTI
and distinctively integrated neuro-navigation, fluorescence-
guided surgery with either FL, 5-ALA, or ICG plays a key
role in the majority of operations. With this technique,
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FIGURE 13 | Implementation of fMRI and DTI in the neuro-navigation system [brain tumor (light blue); tumor segmentation based on the 3d cMPR-image, the hand
motor association areas (magenta), the tongue motor association area (yellow), and the pyramidal tract (darker blue)].
areas of interest are visualized in real time and according
to their specific properties (tumor metabolism with 5-ALA,
disrupted BBB with FL, patterns of blood flow with ICG and
FL). FL-based confocal endomicroscopy, which is still under
scientific evaluation, can further enhance intraoperative accuracy
and efficacy.
The discussed imaging modalities, however, should not be
arbitrarily applied in every patient with a brain tumor, because
such application would counteract the value of an individually
tailored combination of these modalities. In most neurosurgical
departments, this type of imaging workup is only possible with
a high standard of economic and personal competence, and in
the case of well-established interdisciplinary collaboration with
the departments of neuroradiology, neurology, oncology, nuclear
medicine, and neuropathology. Based on this cooperation, the
combination of different imaging modalities carries a huge
benefit for patients in terms of preserving neurological function
while creating the best possible foundation for any type of
adjuvant treatment (6).
FIGURE 14 | Pre-operative MR image (T1-weighted and FLAIR sequences,
axial planes) showing weak contrast-enhancement and marginal edema.
However, some limitations should be clearly stated.
Like any academic institution, we can only offer the
technical modalities available. For example, there is no
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intraoperative MRI to be integrated into our IA. Furthermore,
some inter-observer bias cannot be excluded, especially
in the interpretation of weak or flaw fluorescence in
non-contrast enhancing gliomas. Additionally, the use of
FIGURE 15 | Pre-operative FET-PET showing almost absence of metabolic
activity.
fluorescence-guided confocal endomicroscopy is still under
scientific evaluation.
Our IA was established 10 years ago and has been adapted
according to contemporary scientific perceptions, such as
FIGURE 17 | Post-operative MR image (T1-weighted and FLAIR sequences,
axial planes) confirming complete removal of the tumor.
FIGURE 16 | Implementation of fMRI and DTI in the neuro-navigation system [brain tumor (light blue); tumor segmentation based on a FLAIR 3dspace image (not
shown), inferior frontal language association area (magenta) and ventral language pathway including uncinate fascicle, extreme capsule, inferior longitudinal fascicle
and inferior front-occipital fascicle (green)].
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fluorescence-guided surgery and the integration of FET-PET and
functional data. In 2017, we published our institutional series
before and after the introduction of our IA that was established
simultaneously with the opening of the certified neuro-oncologic
center in 2009. This analysis confirms that the implementation
of the IA has not only greatly contributed to the significantly
prolonged PFS and OS, but has also clearly increased the rate
of gross-total resections of HGG (6). The IA has been broadly
accepted across the disciplines involved in the NOC and serves
as the centerpiece of our weekly neuro-oncologic tumor board.
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